news

News

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

11/16/2024

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation

Data also demonstrates that the...

11/16/2024

EP Lab Digest

News

FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature

11/14/2024

Advancing its Going for Zero mission, OMRON innovation makes AFib screening an integral part of the brand's routine home blood pressure monitoring experience

Advancing its Going for Zero...

11/14/2024

EP Lab Digest

News

New Clinical Data Demonstrate Excellent Lesion Durability With PulseSelect™ Pulsed Field Ablation System in Real-World Setting as Approvals and Adoption Expand Globally

09/30/2024

Medtronic Press Release  GALWAY, Ireland and SYDNEY – September 27, 2024 - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of...

Medtronic Press...

09/30/2024

EP Lab Digest

News

Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System

09/27/2024

Boston Scientific Press Release  MARLBOROUGH, Mass., Sept. 27, 2024 -- Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the...

Boston Scientific Press...

09/27/2024

EP Lab Digest

News

Mainstay Ablation Procedure for Atrial Fibrillation Shows Substantial Benefit Over Sham Procedure

09/03/2024

European Society of Cardiology Press Release  London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial...

European Society of Cardiology...

09/03/2024

EP Lab Digest

News

Atrial Fibrillation Guidelines Focus on Shared and Equal Care, Patient Empowerment, Comorbidities, Evidence-based Management, and Dynamic Re-evaluation

08/30/2024

AF prevalence expected to double in coming decades – new ESC Guidelines focus on tackling comorbidities, education for patients and families, and shared decision making

AF prevalence expected to double...

08/30/2024

EP Lab Digest

News

Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation

07/09/2024

Provides expanded access to FDA and prioritized review of submission

Provides expanded access to FDA...

07/09/2024

EP Lab Digest

News

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib

06/27/2024

Tempus Press Release CHICAGO -- Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tempus...

Tempus Press Release CHICAGO...

06/27/2024

EP Lab Digest

News

Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment

06/11/2024

Kardium Press Release

Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners

Private financing round...

06/11/2024

EP Lab Digest

News

AF Patients on Low Doses of Blood Thinners Have More Bleeding Episodes Than Those on Standard Doses

06/06/2024

American Society of Hematology Press Release

American Society of Hematology Press ...

Risk of bleeding highest in first three months of treatment, even in patients on low doses of direct oral anticoagulants

Risk of bleeding highest in...

06/06/2024

EP Lab Digest

About the Western Atrial Fibrillation Symposium

The Western AF Symposium took place February 23-24, 2024, in Park City, Utah. This internationally recognized meeting unites colleagues and cohorts in the atrial fibrillation community for state of the science education.

The program, with attendees spanning more than 25 different countries, brings together 80+ expert faculty who will discuss the latest advancements in diagnosis and treatment. The program includes challenging case studies, lightning rounds of panel discussions, and roundtables for interactive learning.

From the research lab to the post-discharge office, from the device development setting to the patient bedside, be part of an extensive meeting that supports an agenda of access and equality. Heighten your knowledge and explore new techniques that will improve the lives of patients worldwide.

Join us February 27th to March 1st in Salt Lake City, Utah, for Western AF 2025!

Stay in the know

EP Lab Digest Newsletter

news

About the Western Atrial Fibrillation Symposium

Stay in the know

Specialties

Events

Year Round Education

HMP Global Products